Brand illustration · not a molecular model
01 / What is it?
What is it?
Tesamorelin is a laboratory-made peptide that acts like GHRH, a natural signal that tells the pituitary gland to release growth hormone.
The signalling chain
Follow the connection.
A simplified view of the proposed or studied pathway for Tesamorelin.
Tesamorelin
Why do people find it interesting?
Tesamorelin has been studied for growth-hormone signalling, body composition and visceral fat, which is fat stored deep in the abdomen around internal organs.
What might you notice?
You may notice a smaller waist and less fat around your stomach over 8 to 12 weeks. The peptide encourages your pituitary gland to release more growth hormone and IGF-1. Over time, you may also notice changes in your body shape and better muscle definition.
What happens in your body?
Tesamorelin activates GHRH receptors in the pituitary gland. In simple terms, it tells the body to release more of its own growth hormone in natural pulses.
Keep the context
Important to know
Tesamorelin affects the GH/IGF-1 system, which is involved in many processes throughout the body. You may notice some fluid retention, which can cause swelling in your hands, feet or around your joints. Some people may experience joint pain, muscle aches or discomfort in their arms and legs. Mild redness, itching or pain can also occur at the injection site. Tesamorelin may also increase blood glucose levels during use.
Read the scope & limitations ↗︎Practical context
Dose information from the guide
The guide describes a Tesamorelin administration amount of 2 mg per administration, five or seven days per week.
Look beyond the name
Similar is not the same.
This profile is general information, not medical advice or a recommendation to use a substance. Research findings and individual responses differ. Read the full scope.